在初级Sjögren综合征中严重的头痛对rituximab有反应
Maysoun Kudsi1, Ghina Haidar1, Batoul Hadid1
1Rheumatology Department, Faculty of Medicine, Damascus University, Damascus, Syria.
European journal of case reports in internal medicine
|October 4, 2023
概括
在初级Sjögren综合征 (pSS) 中,对传统治疗无反应的严重头痛可以通过Rituximab有效管理. 这种B细胞消耗疗法为PSS患者的耐火性头痛提供了潜在的解决方案.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 主要Sjögren综合征 (pSS) 是一种系统性自身免疫性疾病,可以影响中枢神经系统,导致严重的,耐治疗的头痛.
- 在pSS中头痛可以表现为紧张,偏头痛或集群类型,对患者的福祉构成重大挑战.
研究的目的:
- 评估Rituximab在治疗初级Sjögren综合征患者严重,耐火性头痛方面的疗效.
- 探索B细胞在与pSS相关的头痛的发病过程中的潜在作用.
主要方法:
- 一个案例介绍的是一个48岁的女性,有10年的pSS病史,经历了严重的,难以治愈的头痛.
- 治疗涉及常规疗法,其次是rituximab (375 mg/m2的IV剂量),随后临床和实验室反应.
主要成果:
- 患者的严重头痛,对止痛药 (黄,NSAID,可代因) 和其他治疗方法 (甲基,阿扎西奥普林) 没有反应,对初始疗法有轻微反应.
- 在接受Rituximab治疗后,患者的头痛完全消失,持续改善两年.
结论:
- 在患有原发性Sjögren综合征的患者中,rituximab治疗可能是严重,耐火性头痛的可行选择.
- 这一成功的结果表明,大脑自动反应性B细胞在这些头痛的发展中可能发挥作用,因此需要进一步调查.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
01:27Open Angle Glaucoma: Treatment
474
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
474
01:21Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
01:26Tonsillitis II: Management
131
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
131
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:28Angle Closure Glaucoma: Treatment
555
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
555